Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis

10.1371/journal.pone.0193112

Saved in:

Bibliographic Details
Main Authors:	Rattanavipapong W., Anothaisintawee T., Teerawattananon Y.
Other Authors:	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
Format:	Article
Published:	Public Library of Science 2020
Subjects:	daclatasvir ledipasvir peginterferon alpha ribavirin sofosbuvir antivirus agent Article budget chronic hepatitis C controlled study cost benefit analysis cost effectiveness analysis cost utility analysis drug cost economic evaluation health care cost health care policy health insurance Hepatitis C virus genotype 3 Markov chain quality adjusted life year quality of life tax Thailand combination drug therapy cost economic model economics female genetics genotype genotyping technique human insurance male Antiviral Agents Budgets Costs and Cost Analysis Drug Therapy, Combination Female Genotype Genotyping Techniques Hepatitis C, Chronic Humans Male Models, Economic Universal Coverage
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/165968
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-165968
record_format	dspace
spelling	sg-nus-scholar.10635-1659682023-10-31T08:45:27Z Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis Rattanavipapong W. Anothaisintawee T. Teerawattananon Y. SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH daclatasvir ledipasvir peginterferon alpha ribavirin sofosbuvir antivirus agent Article budget chronic hepatitis C controlled study cost benefit analysis cost effectiveness analysis cost utility analysis drug cost economic evaluation health care cost health care policy health insurance Hepatitis C virus genotype 3 Markov chain quality adjusted life year quality of life tax Thailand budget chronic hepatitis C combination drug therapy cost economic model economics female genetics genotype genotyping technique human insurance male Antiviral Agents Budgets Costs and Cost Analysis Drug Therapy, Combination Female Genotype Genotyping Techniques Hepatitis C, Chronic Humans Male Models, Economic Universal Coverage 10.1371/journal.pone.0193112 PLoS ONE 13 2 e0193112 2020-03-27T01:05:18Z 2020-03-27T01:05:18Z 2018 Article Rattanavipapong W., Anothaisintawee T., Teerawattananon Y. (2018). Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis. PLoS ONE 13 (2) : e0193112. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0193112 19326203 https://scholarbank.nus.edu.sg/handle/10635/165968 Public Library of Science Unpaywall 20200320
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	daclatasvir ledipasvir peginterferon alpha ribavirin sofosbuvir antivirus agent Article budget chronic hepatitis C controlled study cost benefit analysis cost effectiveness analysis cost utility analysis drug cost economic evaluation health care cost health care policy health insurance Hepatitis C virus genotype 3 Markov chain quality adjusted life year quality of life tax Thailand budget chronic hepatitis C combination drug therapy cost economic model economics female genetics genotype genotyping technique human insurance male Antiviral Agents Budgets Costs and Cost Analysis Drug Therapy, Combination Female Genotype Genotyping Techniques Hepatitis C, Chronic Humans Male Models, Economic Universal Coverage
spellingShingle	daclatasvir ledipasvir peginterferon alpha ribavirin sofosbuvir antivirus agent Article budget chronic hepatitis C controlled study cost benefit analysis cost effectiveness analysis cost utility analysis drug cost economic evaluation health care cost health care policy health insurance Hepatitis C virus genotype 3 Markov chain quality adjusted life year quality of life tax Thailand budget chronic hepatitis C combination drug therapy cost economic model economics female genetics genotype genotyping technique human insurance male Antiviral Agents Budgets Costs and Cost Analysis Drug Therapy, Combination Female Genotype Genotyping Techniques Hepatitis C, Chronic Humans Male Models, Economic Universal Coverage Rattanavipapong W. Anothaisintawee T. Teerawattananon Y. Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
description	10.1371/journal.pone.0193112
author2	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
author_facet	SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH Rattanavipapong W. Anothaisintawee T. Teerawattananon Y.
format	Article
author	Rattanavipapong W. Anothaisintawee T. Teerawattananon Y.
author_sort	Rattanavipapong W.
title	Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
title_short	Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
title_full	Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
title_fullStr	Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
title_full_unstemmed	Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis
title_sort	revisiting policy on chronic hcv treatment under the thai universal health coverage: an economic evaluation and budget impact analysis
publisher	Public Library of Science
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/165968
_version_	1781791997135159296

Revisiting policy on chronic HCV treatment under the Thai Universal Health Coverage: An economic evaluation and budget impact analysis

Similar Items